4/25
02:39 pm
cnmd
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates [Yahoo! Finance]
Low
Report
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates [Yahoo! Finance]
4/25
02:25 pm
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $115.00 to $75.00. They now have an "overweight" rating on the stock.
Low
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $115.00 to $75.00. They now have an "overweight" rating on the stock.
4/25
10:24 am
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Wells Fargo & Company from $98.00 to $77.00. They now have an "equal weight" rating on the stock.
Medium
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Wells Fargo & Company from $98.00 to $77.00. They now have an "equal weight" rating on the stock.
4/25
09:06 am
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $100.00 to $95.00. They now have an "overweight" rating on the stock.
High
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $100.00 to $95.00. They now have an "overweight" rating on the stock.
4/25
08:01 am
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $129.00 to $107.00. They now have a "buy" rating on the stock.
Medium
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $129.00 to $107.00. They now have a "buy" rating on the stock.
4/24
08:31 pm
cnmd
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Medium
Report
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
4/24
04:14 pm
cnmd
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer [Yahoo! Finance]
Medium
Report
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer [Yahoo! Finance]
4/24
04:05 pm
cnmd
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
High
Report
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
4/24
04:03 pm
cnmd
CONMED Corporation Announces First Quarter 2024 Financial Results
High
Report
CONMED Corporation Announces First Quarter 2024 Financial Results
4/15
11:14 am
cnmd
Global Hemorrhoid Treatment Device Market Size To Worth USD 1,073.1 Million By 2033 | CAGR of 4.01% [Yahoo! Finance]
Low
Report
Global Hemorrhoid Treatment Device Market Size To Worth USD 1,073.1 Million By 2033 | CAGR of 4.01% [Yahoo! Finance]
4/10
12:34 pm
cnmd
Should You Invest in CONMED (CNMD)? [Yahoo! Finance]
Low
Report
Should You Invest in CONMED (CNMD)? [Yahoo! Finance]
4/2
04:05 pm
cnmd
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
Low
Report
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
2/27
04:05 pm
cnmd
CONMED Corporation Announces Quarterly Cash Dividend
Low
Report
CONMED Corporation Announces Quarterly Cash Dividend
2/2
11:30 am
cnmd
CONMED (CNMD) Misses on Q4 Earnings, Beats Revenue Estimates [Yahoo! Finance]
Low
Report
CONMED (CNMD) Misses on Q4 Earnings, Beats Revenue Estimates [Yahoo! Finance]
2/1
03:30 pm
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $130.00 to $100.00. They now have an "overweight" rating on the stock.
Low
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $130.00 to $100.00. They now have an "overweight" rating on the stock.
2/1
01:13 pm
cnmd
Conmed Corp (CNMD) Reports Record Revenue Growth and Strong Earnings in Q4 and Full-Year 2023 [Yahoo! Finance]
Low
Report
Conmed Corp (CNMD) Reports Record Revenue Growth and Strong Earnings in Q4 and Full-Year 2023 [Yahoo! Finance]
2/1
10:35 am
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $115.00. They now have an "overweight" rating on the stock.
Low
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $115.00. They now have an "overweight" rating on the stock.
2/1
08:32 am
cnmd
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Wells Fargo & Company from $107.00 to $98.00. They now have an "equal weight" rating on the stock.
Medium
Report
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Wells Fargo & Company from $107.00 to $98.00. They now have an "equal weight" rating on the stock.
2/1
08:03 am
cnmd
CONMED Co. (NYSE: CNMD) had its price target raised by analysts at Needham & Company LLC from $119.00 to $129.00. They now have a "buy" rating on the stock.
Medium
Report
CONMED Co. (NYSE: CNMD) had its price target raised by analysts at Needham & Company LLC from $119.00 to $129.00. They now have a "buy" rating on the stock.
1/31
07:53 pm
cnmd
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings [Yahoo! Finance]
Low
Report
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings [Yahoo! Finance]
1/31
04:21 pm
cnmd
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]
1/31
04:05 pm
cnmd
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
High
Report
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
1/30
10:38 am
cnmd
Ahead of Conmed (CNMD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Ahead of Conmed (CNMD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics [Yahoo! Finance]
1/29
11:30 am
cnmd
ACL Reconstruction Procedures Market Poised for Rapid Growth, Innovative Product Developments to Escalate Demand [Yahoo! Finance]
Low
Report
ACL Reconstruction Procedures Market Poised for Rapid Growth, Innovative Product Developments to Escalate Demand [Yahoo! Finance]